Epithelial-Mesenchymal Transition (EMT).........99–101,
103–105, 107, 108, 112, 115, 118, 121, 152
Extracellular matrix (ECM)..............................7, 23,100,
107, 151, 206
F
Feedback loops...........................................128, 217, 227,
234–236, 252, 254, 255
Fingerprint
biochemical..............................................................328
“First order” phase transition..............................163, 164
Fisher Information Matrix (FIM)...............57, 58,75–77
Fluctuation analysis..............................................277–289
Fluorescence correlation spectroscopy (FCS) ....278, 284
Fluorophores (GFP-tagged)................................278, 288
Force-fields ...................................................308–314, 325
Fractal dimension (FD)............................... 98,105, 106,
109, 111, 132, 134, 136, 137, 143–145, 164,
346, 348
G
Gene expressions..............................9, 11,28–37, 63, 64,
67, 68, 96, 97, 99, 129, 198, 199, 219, 221, 224,
227, 234, 237, 258, 264, 265, 291, 292, 298,
299, 304
Gene set variation analysis (GSVA)....................292, 293,
299, 300
Gene targeting......................................................258, 266
Genetic mutation patterns...................................217, 227
Genetic switch.....................................217, 219, 225, 241
Genomes............................... 3, 8, 9, 23, 29, 33, 36,129,
154, 216, 217, 230, 234, 237, 239, 264,
291–293, 338, 350
Genotype.....................................................217, 237, 264
Genotyping..................................................217, 237, 264
Gibbs free energy...........................................96,109, 149
Glycolitic oscillations....................................................131
Growth (tumor)..................................... 7,129, 132–146,
158, 159, 164
H
HeLa tumor cells........................................149, 151, 153,
156, 159, 164
Hepatocellular carcinoma (HCC)......................217, 219,
222, 223, 225, 227, 228, 230, 232, 234–238,
240, 241
Heterogeneity........................8,133, 173, 188, 196–198,
210, 228, 278, 339, 340
High-speed single-particle tracking (SPT)..................277
Hysteresis........................................................33,100, 236
I
Identifiability (of systems) ..................................... 71, 128
ImageJ.........................................346–348, 352, 354, 357
Inducible systems..........................................................190
Inflammation......................................186, 216–218, 220,
234–236, 239, 240, 328
Intracellular signaling pathways ...................................129
Invariants...................................... 20,45–47, 73, 84, 310
Ising models.........................................................319–323
Isogenic DNA
K
Kreb’s cycle.....................................................35,173, 182
L
Lacunarity.............................................................108, 346
Landscape ................................30, 96, 97,112, 126–136,
138–140, 142–144, 146–154, 156, 157, 159,
161, 162, 164, 198, 237–240, 307
Linear discriminant analysis (LDA).....................332, 333
Linear stability analysis.....................................84–88, 173
Lyapunov function..............................................118, 132,
133, 144, 145, 163
LZ complexity..............................................138, 160–162
M
Mass action kinetics............................174, 175, 177, 179
Mathematical modeling............................. 17, 20, 21, 23,
41–54, 61, 71, 77, 79, 83, 95–121, 126, 129, 200,
205, 206, 209, 211, 248, 251, 255–258, 260,
261, 324, 337, 338
Mathematics.........................................16, 17,19–21, 23,
41–54, 61, 81, 101, 126, 128, 129, 173, 174,
200, 203–207, 209–211, 220, 225, 240, 241,
248, 251, 255–258, 260, 261, 264, 324, 328,
335, 337, 338
Maximum Entropy (Principle of)........................150, 163
Membrane heterogeneity.............................................278
Metabolic rates.............................................131, 143–145
Metabolism........................................ 7, 33, 37,144, 146,
148–150, 152, 156, 158, 163, 173, 196, 218,
219, 221, 223, 234, 334
Metabolomics.............................258, 328–335, 350, 352
Metastasis...........................................133, 134, 136, 144,
148, 151, 152, 158, 159, 248–250
Metastatic cells.....................................................141, 216
Microenvironment..........................................7–9, 11, 24,
36, 99, 100, 129, 151, 157, 216, 346
MicroRNAs (miRNAs)................................ 11,219, 222,
249, 252, 255, 264–266, 268, 269, 272
Model analysis..................................................49–52, 257
Modeling....................................... 17, 20, 21, 23,41–54,
57, 59, 61, 63, 67, 126, 128, 129, 139, 160, 172,
174–177, 179, 181, 190, 200, 203–211, 220,
225, 248–251, 255–258, 260, 261, 263, 264,
272, 278, 308, 311, 312, 319, 338
Modular....................179, 217, 218, 222, 224, 225, 240
362
SYSTEMSBIOLOGY
Index